Invossa Fallout: Call For Review Of All Korea-Approved Cell Therapies

31 May 2019

Although the big decision has been made for Invossa in Korea, things have not settled down and there have been calls for re-examination of all approved cell therapies, the recall of R&D grants provided to Kolon and expansion of a probe into the company’s leadership and government officials.

Storm — Invossa Fallout Might Spread To Other Cell Therapies • Source: Shutterstock

Following the shocking withdrawal of approval in South Korea of Kolon Life Science Inc.’s cell and gene therapy Invossa (TG-C), a local pharmacist organization has questioned whether the problems relate only to Invossa and has urged the government to launch a full-scale re-examination of all 16 cell therapies approved in the country.

The Invossa incident has revealed the Ministry of Food and Drug Safety’s (MFDS) weak management of cell and gene therapies,...